These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1005 related articles for article (PubMed ID: 26325310)
1. Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: Penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability. He W; Yang K; Fan L; Lv Y; Jin Z; Zhu S; Qin C; Wang Y; Yin L Int J Pharm; 2015 Nov; 495(1):9-18. PubMed ID: 26325310 [TBL] [Abstract][Full Text] [Related]
2. Denatured protein-coated docetaxel nanoparticles: Alterable drug state and cytosolic delivery. Zhang L; Xiao Q; Wang Y; Zhang C; He W; Yin L Int J Pharm; 2017 May; 523(1):1-14. PubMed ID: 28323094 [TBL] [Abstract][Full Text] [Related]
3. Bile salt/phospholipid mixed micelle precursor pellets prepared by fluid-bed coating. Dong F; Xie Y; Qi J; Hu F; Lu Y; Li S; Wu W Int J Nanomedicine; 2013; 8():1653-63. PubMed ID: 23641154 [TBL] [Abstract][Full Text] [Related]
4. Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug. Mohsin K; Alamri R; Ahmad A; Raish M; Alanazi FK; Hussain MD Int J Nanomedicine; 2016; 11():2829-38. PubMed ID: 27366063 [TBL] [Abstract][Full Text] [Related]
5. Biodegradable nanoparticles from prosopisylated cellulose as a platform for enhanced oral bioavailability of poorly water-soluble drugs. Kenechukwu FC; Dias ML; Ricci-Júnior E Carbohydr Polym; 2021 Mar; 256():117492. PubMed ID: 33483021 [TBL] [Abstract][Full Text] [Related]
6. Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations. Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S Int J Pharm; 2016 Mar; 501(1-2):18-31. PubMed ID: 26812610 [TBL] [Abstract][Full Text] [Related]
7. Exploring the potential of self-assembled mixed micelles in enhancing the stability and oral bioavailability of an acid-labile drug. Zhang X; Wang H; Zhang T; Zhou X; Wu B Eur J Pharm Sci; 2014 Oct; 62():301-8. PubMed ID: 24956461 [TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of proliposomes and self micro-emulsifying drug delivery system for improved oral bioavailability of nisoldipine. Nekkanti V; Rueda J; Wang Z; Betageri GV Int J Pharm; 2016 May; 505(1-2):79-88. PubMed ID: 27041124 [TBL] [Abstract][Full Text] [Related]
9. Nanosized Liposomes Containing Bile Salt: A Vesicular Nanocarrier for Enhancing Oral Bioavailability of BCS Class III Drug. Arafat M; Kirchhoefer C; Mikov M; Sarfraz M; Löbenberg R J Pharm Pharm Sci; 2017; 20(0):305-318. PubMed ID: 28885915 [TBL] [Abstract][Full Text] [Related]
11. Aminoclay-lipid hybrid composite as a novel drug carrier of fenofibrate for the enhancement of drug release and oral absorption. Yang L; Shao Y; Han HK Int J Nanomedicine; 2016; 11():1067-76. PubMed ID: 27042061 [TBL] [Abstract][Full Text] [Related]
12. Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading. Li P; Tan A; Prestidge CA; Nielsen HM; Müllertz A Int J Pharm; 2014 Dec; 477(1-2):390-8. PubMed ID: 25455781 [TBL] [Abstract][Full Text] [Related]
13. Development of daidzein nanosuspensions: Preparation, characterization, in vitro evaluation, and pharmacokinetic analysis. Wang H; Xiao Y; Wang H; Sang Z; Han X; Ren S; Du R; Shi X; Xie Y Int J Pharm; 2019 Jul; 566():67-76. PubMed ID: 31125715 [TBL] [Abstract][Full Text] [Related]
14. Study on the release of fenofibrate nanosuspension in vitro and its correlation with in situ intestinal and in vivo absorption kinetics in rats. Xu Y; Wang Y; Li XM; Huang Q; Chen W; Liu R; Chen B; Wei P Drug Dev Ind Pharm; 2014 Jul; 40(7):972-9. PubMed ID: 23692349 [TBL] [Abstract][Full Text] [Related]
15. Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium. Borkar N; Xia D; Holm R; Gan Y; Müllertz A; Yang M; Mu H Eur J Pharm Sci; 2014 Jan; 51():204-10. PubMed ID: 24134899 [TBL] [Abstract][Full Text] [Related]
16. Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt. Chen Y; Lu Y; Chen J; Lai J; Sun J; Hu F; Wu W Int J Pharm; 2009 Jul; 376(1-2):153-60. PubMed ID: 19394416 [TBL] [Abstract][Full Text] [Related]
17. Optimization of a PGSS (particles from gas saturated solutions) process for a fenofibrate lipid-based solid dispersion formulation. Pestieau A; Krier F; Lebrun P; Brouwers A; Streel B; Evrard B Int J Pharm; 2015 May; 485(1-2):295-305. PubMed ID: 25796121 [TBL] [Abstract][Full Text] [Related]
18. Novel self-nanoemulsifying self-nanosuspension (SNESNS) for enhancing oral bioavailability of diacerein: Simultaneous portal blood absorption and lymphatic delivery. El-Laithy HM; Basalious EB; El-Hoseiny BM; Adel MM Int J Pharm; 2015 Jul; 490(1-2):146-54. PubMed ID: 26002566 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of a self-microemulsifying drug delivery system for the poorly soluble drug fenofibrate. Cho YD; Park YJ Arch Pharm Res; 2014 Feb; 37(2):193-203. PubMed ID: 23754165 [TBL] [Abstract][Full Text] [Related]
20. Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption. Zhou X; Zhang X; Ye Y; Zhang T; Wang H; Ma Z; Wu B Int J Pharm; 2015 Feb; 479(2):391-8. PubMed ID: 25556104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]